Cardiac glycoside cerberin exerts anticancer activity through PI3K/AKT/mTOR signal transduction inhibition.

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  T. Bradshaw,et al.  Discovery of a highly active anticancer analogue of cardamonin that acts as an inducer of caspase-dependent apoptosis and modulator of the mTOR pathway. , 2018, Fitoterapia.

[3]  W. Kreis,et al.  Cardiac Glycoside Glucoevatromonoside Induces Cancer Type-Specific Cell Death , 2018, Front. Pharmacol..

[4]  R. An,et al.  RTN1-C mediates cerebral ischemia/reperfusion injury via ER stress and mitochondria-associated apoptosis pathways , 2017, Cell Death and Disease.

[5]  Z. Dlamini,et al.  African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugs. , 2017, Experimental and molecular pathology.

[6]  T. Winder,et al.  Development of chemotherapeutics in oncology: is there anything new? , 2017, memo - Magazine of European Medical Oncology.

[7]  J. Yakisich,et al.  Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers , 2017, Cell Death Discovery.

[8]  M. Diederich,et al.  Cardiac glycosides: From molecular targets to immunogenic cell death , 2017, Biochemical pharmacology.

[9]  S. Fiering,et al.  Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer , 2016, Oncogenesis.

[10]  Yuefei Wang,et al.  Cardenolides from the Apocynaceae family and their anticancer activity. , 2016, Fitoterapia.

[11]  C. Twelves,et al.  Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer. , 2016, Critical reviews in oncology/hematology.

[12]  B. Dai,et al.  Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma , 2016, Scientific Reports.

[13]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[14]  T. Bradshaw,et al.  In vitro anticancer properties and biological evaluation of novel natural alkaloid jerantinine B. , 2016, Cancer letters.

[15]  V. J. Raja.  Biological characterisation of a novel and naturally isolated indole alkaloid , 2015 .

[16]  S. Shankar,et al.  PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth , 2015, Oncotarget.

[17]  C. Wiart.  Medicinal plants of the Asia-Pacific , 2015 .

[18]  Stephanie L. Ham,et al.  Phytochemicals potently inhibit migration of metastatic breast cancer cells. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[19]  R. Santelli,et al.  Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol , 2015, Molecular Cancer.

[20]  M. Ark,et al.  Ouabain induces Rho-dependent rock activation and membrane blebbing in cultured endothelial cells , 2015, Molecular Biology.

[21]  L. Fanton,et al.  The principal toxic glycosidic steroids in Cerbera manghas L. seeds: identification of cerberin, neriifolin, tanghinin and deacetyltanghinin by UHPLC-HRMS/MS, quantification by UHPLC-PDA-MS. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[22]  T. Bradshaw,et al.  Novel antitumour indole alkaloid, Jerantinine A, evokes potent G2/M cell cycle arrest targeting microtubules , 2014, Investigational New Drugs.

[23]  M. López-Lázaro,et al.  Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides , 2014, BioMed research international.

[24]  H. Seo,et al.  Trichosanthes kirilowii Ethanol Extract and Cucurbitacin D Inhibit Cell Growth and Induce Apoptosis through Inhibition of STAT3 Activity in Breast Cancer Cells , 2013, Evidence-based complementary and alternative medicine : eCAM.

[25]  V. Adam,et al.  From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment. , 2013, Anti-cancer agents in medicinal chemistry.

[26]  Chuan-Ming Xie,et al.  Cardiac glycosides block cancer growth through HIF-1α- and NF-κB-mediated Plk1. , 2013, Carcinogenesis.

[27]  H. Gelderblom,et al.  Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials , 2013, Investigational New Drugs.

[28]  Letícia Rangel,et al.  Cancer Treatment - Conventional and Innovative Approaches , 2013 .

[29]  V. Pongrakhananon.  Anticancer Properties of Cardiac Glycosides , 2013 .

[30]  Hannah M Jones,et al.  Predicting pharmacokinetic profiles using in silico derived parameters. , 2013, Molecular pharmaceutics.

[31]  L. Zitvogel,et al.  Trial watch , 2013, Oncoimmunology.

[32]  T. Kundu,et al.  Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells , 2013, BMC Cancer.

[33]  Ping-Chang Yang,et al.  Western Blot: Technique, Theory, and Trouble Shooting , 2012, North American journal of medical sciences.

[34]  H. Wakimoto,et al.  Polo‐Like Kinase 1 Inhibition Kills Glioblastoma Multiforme Brain Tumor Cells in Part Through Loss of SOX2 and Delays Tumor Progression in Mice , 2012, Stem cells.

[35]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[36]  Xinyuan Zhang,et al.  The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation. , 2011, International journal of pharmaceutics.

[37]  R. Giugliano,et al.  Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine. , 2011, Critical pathways in cardiology.

[38]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[39]  J. Grandis,et al.  STAT3 signaling: anticancer strategies and challenges. , 2011, Molecular interventions.

[40]  Edward H. Kerns,et al.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery , 2010, Nature Reviews Drug Discovery.

[41]  Y. Pei,et al.  Chemical constituents from the leaves of Cerbera manghas , 2010 .

[42]  Eleftherios P. Diamandis,et al.  Novel therapeutic applications of cardiac glycosides , 2008, Nature Reviews Drug Discovery.

[43]  Gianluca Bontempi,et al.  Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity , 2008, Molecular Cancer Therapeutics.

[44]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[45]  M. Hämäläinen,et al.  Predicting the intestinal absorption potential of hits and leads. , 2004, Drug discovery today. Technologies.

[46]  F. Bévalot,et al.  Cerbera odollam: a 'suicide tree' and cause of death in the state of Kerala, India. , 2004, Journal of ethnopharmacology.

[47]  K. Chantrapromma,et al.  New cytotoxic cardenolide glycoside from the seeds of Cerbera manghas. , 2004, Chemical & pharmaceutical bulletin.

[48]  S. Laphookhieo,et al.  Cytotoxic cardenolide glycoside from the seeds of Cerbera odollam. , 2004, Phytochemistry.

[49]  C. Twelves,et al.  Oral cancer treatment: developments in chemotherapy and beyond , 2002, British Journal of Cancer.

[50]  J. Pezzuto,et al.  Activity-guided isolation of constituents of Cerbera manghas with antiproliferative and antiestrogenic activities. , 2000, Bioorganic & medicinal chemistry letters.

[51]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[52]  V. Fadok,et al.  The role of phosphatidylserine in recognition of apoptotic cells by phagocytes , 1998, Cell Death and Differentiation.

[53]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[54]  F. Abe,et al.  Cardenolide Monoglycosides from the Leaves of Cerbera odollam and Cerbera manghas ( Cerbera . III) , 1987 .

[55]  D. Radford,et al.  Naturally occurring cardiac glycosides. , 1987, The Medical journal of Australia.

[56]  D. Radford,et al.  Naturally occurring cardiac glycosides , 1986 .

[57]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[58]  Y. F. Poon,et al.  Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx , 1980, International journal of cancer.

[59]  H. Okabe,et al.  Studies on Cerbera. II. Cerbinal and Its Derivatives, Yellow Pigments in the Bark of Cerbera manghas L. , 1977 .

[60]  F. Abe,et al.  Studies on Cerbera. I. Cardiac Glycosides in the Seeds, Bark, and Leaves of Cerbera manghas L. , 1977 .

[61]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[62]  E. Harlow,et al.  Bradford assay. , 2006, CSH protocols.